Genentech’s biosimilar complaint against Amgen dismissed

Judge Sleet of the District of Delaware has dismissed Genentech’s biosimilar complaint against Amgen for lack of subject matter jurisdiction, and granted 45 days for an amended complaint to be filed
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: